Therapeutic Pet Nutrition Market Report 2026

The therapeutic pet nutrition market size has grown strongly in recent years. It will grow from $3.74 billion in 2025 to $4.06 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising pet ownership globally, increasing awareness regarding pet health and wellness, growing prevalence of obesity and digestive disorders in pets, expansion of veterinary healthcare infrastructure, increasing demand for premium and specialized pet food products.

The therapeutic pet nutrition market size is expected to see strong growth in the next few years. It will grow to $5.7 billion by 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing adoption of personalized therapeutic pet nutrition solutions, rising investment in veterinary nutritional research and development, growing demand for renal and joint health dietary products, expansion of online pet nutrition retail channels, increasing focus on preventive and functional pet healthcare. Major trends in the forecast period include growing demand for prescription diets for chronic pet health conditions, increasing adoption of functional treats for digestive and immune support, rising preference for low allergen and specialized protein pet diets, expanding use of probiotics and omega fatty acid supplements in pet nutrition, increasing focus on preventive healthcare and long-term wellness management in pets.

The rising pet ownership rates are expected to propel the growth of the therapeutic pet nutrition market going forward. Pet ownership rates refer to the percentage of households or individuals that own one or more pets within a particular population or region. The increase in pet ownership rates is driven by growing awareness regarding the emotional and health benefits associated with pets, as they provide companionship, alleviate stress, and enhance overall well-being. Therapeutic pet nutrition supports the increasing pet ownership rates by providing specialized diets that improve pets' health and longevity, giving pet owners greater confidence in delivering optimal care for their animals. For instance, in April 2025, according to the American Pet Products Association (APPA), 94 million households in the United States owned at least one pet, representing an increase from 82 million in 2023. Therefore, the increasing pet ownership rates are driving the growth of the therapeutic pet nutrition market.

Leading companies operating in the therapeutic pet nutrition market are concentrating on developing advanced dietary solutions, such as glycemic support diets and veterinary fresh nutrition offerings, to improve pet health outcomes, manage chronic conditions, and support overall well-being. Therapeutic pet nutrition refers to specially formulated diets designed to address specific medical conditions, such as diabetes, gastrointestinal disorders, or dermatological issues, supporting clinical management and improving quality of life. For instance, in January 2026, Royal Canin previewed its upcoming therapeutic innovations at the Veterinary Meeting & Expo (VMX) 2026. The innovations include GLYCOADVANCED, a feline diet developed for safe caloric restriction in overweight diabetic cats to support healthy blood glucose levels and body weight, along with home care kits and Veterinary Fresh Nutrition diets designed to provide comprehensive nutritional support for gastrointestinal, dermatology, and urinary conditions, bridging the gap between diagnosis and treatment compliance while enabling pet owners to improve pet health outcomes.

In September 2024, Nestlé Purina PetCare collaborated with University of California, Davis School of Veterinary Medicine. Through this collaboration, Nestlé Purina aims to advance scientific research in pet health and nutrition by leveraging the veterinary expertise of the University of California Davis to support the development of innovative nutritional solutions that promote overall pet wellness. University of California is a US-based provider of specialized therapeutic pet nutrition services through its Veterinary Medical Teaching Hospital (VMTH).

Major companies operating in the therapeutic pet nutrition market are Archer Daniels Midland, DSM-Firmenich, Zoetis Inc., Ceva Santé Animale, The Farmer’s Dog Inc., Dechra Pharmaceuticals Plc, Vetoquinol SA, Merrick Pet Care Inc., Heska Corporation, Stella And Chewy’s LLC, Diamond Pet Foods Inc., JustFoodForDogs LLC, Farmina Pet Foods, Open Farm Inc., Nestlé Purina PetCare Co., Husse Inc., EmerAid LLC, Ziwi Pets, Mars Petcare, Rayne Clinical Nutrition LLC, Trovet, Arden Grange Ltd.

North America was the largest region in the therapeutic pet nutrition market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic pet nutrition market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the therapeutic pet nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic pet nutrition market consists of sales of probiotic capsules, omega-3 treats, hypoallergenic patties, and mineral-fortified snacks. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.